2004
DOI: 10.1038/emm.2004.16
|View full text |Cite
|
Sign up to set email alerts
|

Association study of the angiotensin-converting enzyme (ACE) gene G2350A dimorphism with myocardial infarction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
4
1

Year Published

2008
2008
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 26 publications
(22 reference statements)
0
4
1
Order By: Relevance
“…A allele carrier is an independent risk factor for acute MI after adjustments for age, gender, BMI, smoking status, blood pressure, and plasma levels of lipids and apolipoproteins. This result was not in agreement with the only reported study carried out in the Emirati population, 29 which showed no significant difference in distribution of the 3 genotypes between MI patients and controls (χ 2 = 3.1, P = .217). However, in their study, the ACE2350G>A genotypes were not in agreement with predicted Hardy-Weinberg equilibrium values, either in the normal control group or in acute MI patients.…”
Section: Discussioncontrasting
confidence: 95%
“…A allele carrier is an independent risk factor for acute MI after adjustments for age, gender, BMI, smoking status, blood pressure, and plasma levels of lipids and apolipoproteins. This result was not in agreement with the only reported study carried out in the Emirati population, 29 which showed no significant difference in distribution of the 3 genotypes between MI patients and controls (χ 2 = 3.1, P = .217). However, in their study, the ACE2350G>A genotypes were not in agreement with predicted Hardy-Weinberg equilibrium values, either in the normal control group or in acute MI patients.…”
Section: Discussioncontrasting
confidence: 95%
“…Several investigators found no association with the occurrence of either CAD, MI 46–50 or long-term clinical outcomes, 51 while others demonstrated a positive association between especially the D allele and ischemic heart disease generally or for certain subgroups of patients. 31,37,46,48–50,5254 Assessing six different genetic polymorphisms of the RAS components in a group of CAD patients was based on the study hypothesis that the influence of genetic polymorphisms on the activity of ACE or Ang II receptors could show measurable effects on CRP plasma levels in atherosclerosis. This could even provide clues relating ACE I/D genetic polymorphism to the inflammatory component of atherosclerosis in patients with CAD.…”
Section: Discussionmentioning
confidence: 99%
“…35 PCR amplification of A-240T, A2350G, M235T, A1166C, and C3123A was performed using primers mentioned in Table 1. 25,34,3640 In each reaction, 100–200 ng of genomic DNA was amplified in 15 µl of 1×PCR master mix (67 mM Tris base, pH 8.8, 16.6 mM (NH4) 2SO4, 2 mM MgCl2, 0.1% Tween-20, 200 µM deoxyribonucleotide triphosphates (dNTPs), 5% glycerol, 100 µg/ml cresol red) containing 0.2–2.0 µM of each primer and 0.5 U of Taq DNA polymerase (Cinnagen Inc, Tehran, Iran). All genes were amplified under the same procedure, which is of great advantage to reduce workload.…”
Section: Methodsmentioning
confidence: 99%
“…The extracted DNAs were stored at -20 °C for polymerase chain reaction restriction fragment length polymorphism (PCR–RFLP) analysis. PCR amplification of G8790A and A2350G was performed using primers mentioned in Table 2 [ 51 , 52 ]. PCR amplification/detection of G8790A was performed as described previously [ 53 ].…”
Section: Methodsmentioning
confidence: 99%